Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications measuring nutrient reduction benefits policy analysis using linked non market valuation
… Economic Qualitative Inquiry, Policy, and Access Our focused research will enable you to … and policymakers. With so many public, private, and non-traditional payers and their ever-changing priorities, … current and after launch that impact your product’s market access Product value summary: Clinical, economic , …
… how your patients and other decision-makers perceive the benefits of your treatment features and their tolerance for … Benefit-risk preference studies demonstrate the net benefits of treatments by quantifying the relative importance of benefits and risks and a patient’s maximum acceptable risk …
… clinical trials through protocol development, statistical analysis plans, analyses, and reporting - Perform stand-alone … observational studies designed to derive utility data using a health preference measure (such as EQ-5D) - Perform … such as NICE, SMC, CDR, and PBAC), value messaging , and publications A Team Approach Let our multidisciplinary team …
… Benefit-Risk Assessment Do your product’s benefits outweigh its potential risks? More importantly, do … and patient perspectives Selecting the best metrics for measuring key benefits and risks that will resonate with … in the same way in both short and long-term studies or using the same units. By engaging with our team early in the …
… value it? Willingness-to-pay (WTP) can be estimated using a number of stated-preference methods including discrete-choice experiments and contingent valuation. WTP studies provide a monetary measure of benefit … actionable results to inform your drug development and market access strategies. For your project, we conduct the …
… Multi-Criteria Decision Analysis Most drug development and commercialization choices … attribute. Image Inform Your Strategies in Development, Market Access and Post-Approval Decisions From making drug … decision makers are willing to strike between treatment benefits and risks. MCDA provides quantitative information …
… Clinical trial design and consulting to optimize the analysis of COA data, as well as the value of results based on COA endpoints Gap analysis of data supporting the use of COAs for your intended …
… methods have historically been used in a variety of non-healthcare industries. Our experts have been applying … the potential and positioning of a treatment in the market. Preference studies can be used to help you with: … methods—discrete choice experiments (DCE) / conjoint analysis, best-worst scaling, threshold technique, and …
… for clinical trials, including: Protocol and statistical analysis plan (SAP) development Sample size calculations … (QoL) assessments may be used to demonstrate additional benefits to patients and provide compelling evidence for … costing to clinical trial data and provide analysis of non-normal cost and resource utilization data to demonstrate …
… Market Research We can collaborate with you to develop and … for your pharmaceutical products and/or devices. Our market research services include: Qualitative research … Designing and conducting sensory panels Disseminating market research results (e.g., scientific conferences, peer-reviewed publications ) …